As of 2025-05-16, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 576.19 USD. This relative valuation is based on P/E multiples. With the latest stock price at 584.99 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -1.5%.
The range of the Relative Valuation is 511.27 - 593.41 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 14.2x | 14.0x |
| Forward P/E multiples | 12.8x - 14.4x | 14.2x |
| Fair Price | 511.27 - 593.41 | 576.19 |
| Upside | -12.6% - 1.4% | -1.5% |
| Date | P/E |
| 2025-05-16 | 14.12 |
| 2025-05-15 | 14.04 |
| 2025-05-14 | 13.71 |
| 2025-05-13 | 13.78 |
| 2025-05-12 | 13.81 |
| 2025-05-09 | 12.67 |
| 2025-05-08 | 13.14 |
| 2025-05-07 | 13.46 |
| 2025-05-06 | 13.40 |
| 2025-05-05 | 14.48 |
| 2025-05-02 | 14.53 |
| 2025-05-01 | 14.16 |
| 2025-04-30 | 14.37 |
| 2025-04-29 | 13.65 |
| 2025-04-28 | 14.66 |
| 2025-04-25 | 14.46 |
| 2025-04-24 | 14.39 |
| 2025-04-23 | 14.11 |
| 2025-04-22 | 14.05 |
| 2025-04-21 | 13.47 |
| 2025-04-17 | 13.51 |
| 2025-04-16 | 13.18 |
| 2025-04-15 | 13.39 |
| 2025-04-14 | 13.70 |
| 2025-04-11 | 13.30 |
| 2025-04-10 | 13.11 |
| 2025-04-09 | 13.84 |
| 2025-04-08 | 13.36 |
| 2025-04-07 | 13.75 |
| 2025-04-04 | 13.76 |
| 2025-04-03 | 14.65 |
| 2025-04-02 | 15.01 |
| 2025-04-01 | 14.81 |
| 2025-03-31 | 15.22 |
| 2025-03-28 | 15.29 |
| 2025-03-27 | 15.26 |
| 2025-03-26 | 15.36 |
| 2025-03-25 | 15.22 |
| 2025-03-24 | 15.86 |
| 2025-03-21 | 15.80 |
| 2025-03-20 | 15.90 |
| 2025-03-19 | 16.13 |
| 2025-03-18 | 15.96 |
| 2025-03-17 | 16.28 |
| 2025-03-14 | 16.00 |
| 2025-03-13 | 16.33 |
| 2025-03-12 | 16.55 |
| 2025-03-11 | 17.23 |
| 2025-03-10 | 17.87 |
| 2025-03-07 | 16.98 |